F10.2 F11.2 F12.2 F13.2 F14.2 F15.2 F16.2 F17.2 F18.2 F19.2
Conditions
Interventions
Group 1: Immediate condition: receives DELTA-JU treatment after initial assessment
Group 2: Waitlist condition: receives DELTA-JU treatment 16 weeks after initial assessment
Sponsors
Technische Universität Dresden, Faculty of Medicine, Dept. of Child and Adolescent Psychiatry
Eligibility
Sex/Gender
All
Age
12 Years to 17 Years
Inclusion criteria
Inclusion criteria: SUD diagnosis or chronic substance use during the past
Exclusion criteria
Exclusion criteria: - intelligence quotient is below 70 - did not attend any of the 16 sessions for whatever reason (applies only to Baseline-FollowUp analyses) - study participation was discontinued due to an adverse event (applies only to Baseline-FollowUp analyses)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name: SUD severity Method of measurement: scores from AUDIT, DUDIT, FTND Timepoints: baseline, 16-week follow-up Outcome name: Craving Method of measurement: MaCS score Timepoints: baseline, 16-week follow-up Outcome name: Substance use Method of measurement: past-month quantity & frequency reported in generic interview Timepoints: baseline, 16-week follow-up Outcome name: SUD-related knowledge Method of measurement: scoring of items in generic questionnaires (GEJ, GEB) Timepoints: baseline, 16-week follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome name(s): Severity of psychopathology. Method of measurement: BDI-II, PQ-16, UCLA-PTSD, YSR questionnaires. Timpoints: baseline, 16-week follow-up. Outcome name: life satisfaction. Method of measurement: SWLS questionnaire. Timpoints: baseline, 16-week follow-up. Outcome name: perceived stress. Method of measurement: ERI-S-10, PSS-10 questionnaires. Timpoints: baseline, 16-week follow-up. | — |
Countries
Germany
Outcome results
None listed